Anti-Müllerian hormone and risk of ovarian cancer in nine cohorts

Author:

Jung Seungyoun1ORCID,Allen Naomi2,Arslan Alan A.34,Baglietto Laura56,Barricarte Aurelio789,Brinton Louise A.10ORCID,Egleston Brian L.11,Falk Roni T.10,Fortner Renée T.12ORCID,Helzlsouer Kathy J.1314,Gao Yutang15,Idahl Annika16,Kaaks Rudolph12,Krogh Vittorio17ORCID,Merritt Melissa A.18,Lundin Eva19,Onland-Moret N. Charlotte20,Rinaldi Sabina21,Schock Helena12,Shu Xiao-Ou22,Sluss Patrick M.23,Staats Paul N.24,Sacerdote Carlotta25ORCID,Travis Ruth C.26,Tjønneland Anne27,Trichopoulou Antonia2829,Tworoger Shelley S.3031,Visvanathan Kala14,Weiderpass Elisabete32333435,Zeleniuch-Jacquotte Anne4,Dorgan Joanne F.1

Affiliation:

1. Department of Epidemiology and Public Health; University of Maryland School of Medicine; Baltimore MD

2. Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health; University of Oxford; Oxford United Kingdom

3. Department of Obstetrics and Gynecology; New York University School of Medicine; New York, NY

4. Departments of Population Health and Environmental Medicine and Perlmutter Cancer Center; New York University School of Medicine; New York NY

5. Cancer Epidemiology Centre, Cancer Council of Victoria; Melbourne Australia

6. Centre for Epidemiology and Biostatistics, School of Population and Global Health; University of Melbourne; Melbourne Australia

7. Navarra Public Health Institute; Pamplona Spain

8. Navarra Institute for Health Research (IdiSNA), Pamplona; Spain

9. CIBER Epidemiology and Public Health CIBERESP; Madrid Spain

10. Division of Cancer Epidemiology and Genetics; National Cancer Institute; Bethesda MD

11. Fox Chase Cancer Center; Philadelphia PA

12. Division of Cancer Epidemiology; German Cancer Research Cancer; Heidelberg Germany

13. Division of Cancer Control and Population Sciences; National Cancer Institute; Bethesda MD

14. Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health; Baltimore MD

15. Department of Epidemiology; Shanghai Cancer Institute; Shanghai China

16. Department of Clinical Sciences, Obstetrics and Gynecology; Umeå University; Umeå Sweden

17. Fondazione IRCCS Istituto Nazionale dei Tumori; Milano Italy

18. Department of Epidemiology and Biostatistics, School of Public Health; Imperial College London; London United Kingdom

19. Department of Medical Biosciences; Pathology, and Public Health and Clinical Medicine: Nutritional Research, Umeå University; Umeå Sweden

20. Department of Epidemiology; UMC Utrecht Julius Center; Uretcht The Netherlands

21. International Agency for Research on Cancer; Lyon France

22. Department of Epidemiology; Vanderbilt University School of Medicine; Nashville TN

23. Department of Pathology; Harvard Medical School; Boston MA

24. Department of Pathology; University of Maryland School of Medicine; Baltimore MD

25. Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO); Turin Italy

26. Cancer Epidemiology Unit, University of Oxford; Oxford, United Kingdom

27. Danish Cancer Society Research Center; Copenhagen Denmark

28. Hellenic Health Foundation; Athens Greece

29. WHO Collaborating Center for Nutrition and Health, Unit of Nutritional Epidemiology and Nutrition in Public Health, Department of Hygiene, Epidemiology and Medical Statistics; University of Athens Medical School; Athens Greece

30. Department of Epidemiology, Harvard T.H. Chan School of Public Health; Boston MA

31. Channing Division of Network Medicine; Bringham and Women's Hospital and Harvard Medical School; Boston MA

32. Department of Community Medicine, Faculty of Health Sciences; University of Tromsø, The Arctic University of Norway; Tromsø Norway

33. Department of Research; Cancer Registry of Norway, Institute of Population-Based Cancer Research; Oslo Norway

34. Department of Medical Epidemiology and Biostatistics; Karolinska Institutet; Stockholm Sweden

35. Genetic Epidemiology Group, Folkhälsan Research Center; Helsinki Finland

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference42 articles.

1. Regulation of ovarian function: the role of anti-Mullerian hormone;Durlinger;Reproduction,2002

2. Anti-Mullerian hormone: a new marker for ovarian function;Visser;Reproduction,2006

3. Mullerian inhibiting substance/anti-Mullerian hormone: a potential therapeutic agent for human ovarian and other cancers;MacLaughlin;Future Oncol.,2010

4. Ovarian surface epithelium: biology, endocrinology, and pathology;Auersperg;Endocrine Rev.,2001

5. Human mullerian inhibiting substance inhibits tumor growth in vitro and in vivo;Chin;Cancer Res.,1991

Cited by 7 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3